|
|
|
Corporate Profile:
Bayhill Therapeutics
| Summary: |
Bayhill Therapeutics is focused on using its proprietary therapeutic BHT-DNA™ platform to develop a pipeline of novel and targeted treatment candidates to restore tolerance in patients with autoimmune diseases.
|
| Address: |
1810 Gateway Drive
Suite 150
San Mateo, CA 94404 |
| Phone
#'s: |
| Main |
(650) 320-2800 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s: |
| Main |
(650) 320-2815 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
